South Korea: Agricultural Biotechnology Annual

  |   Attaché Report (GAIN)   |   KS2022-0024

Korea is in the process of revising its Living Modified Organism (LMO) Act. Once completed, these revisions will define Korea’s regulatory policies for products that utilize innovative technologies, including genome editing. Finalized changes to the LMO Act are expected by the end of 2022 with implementation planned for the end of 2023. Additionally, Korea has announced mandatory biotech labeling will be required for all products containing biotech ingredients beginning in 2026.

Related Reports

Chinese buyers are traveling back to the United States and showing strong interest in U.S. products. Since the reopening of China to travel, four delegations have participation in reverse trade missions to the United States with many others traveling...
Attaché Report (GAIN)

United Kingdom: UK Import Controls Update

The United Kingdom's Border Target Operating Model, its post-Brexit system of import controls on animals, animal products, plants, and plant products, is set to come into effect on exports from the EU on January 31, 2024, and from the rest of the...
South Africa’s sorghum imports are expected to be elevated over the next two marketing years on lower production coupled with lower stocks as production continues to decline. Sorghum production in South Africa dropped over the past two decades as...